László Őrfi

Also affiliated with Vichem Chemie (Hungary)

Biochemistry, Genetics and Molecular BiologyMedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma”.

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Bioorganic & Medicinal Chemistry Letters(2018)10.1016/j.bmcl.2018.01.002

N/A

0.546DataRank · unranked

37 citations

Mária Balogh, Péter Bánhegyi, Sándor Boros, Nóra Breza, Judit Dobos +9 more

Identification and Validation of an inhibitor of the protein kinases PIM and DYRK

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.22.683941

N/A

0.104DataRank · unranked

1 citations

Prabhadevi Venkataramani, Elad Elkayam, Keith Rivera, Ankur Garg, István Szabadkai +5 more